| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/KEI279 |
| P8608 | Fatcat ID | release_grriiw4agnf6rfrid3teelkzga |
| P3181 | OpenCitations bibliographic resource ID | 2428791 |
| P698 | PubMed publication ID | 16403826 |
| P2093 | author name string | A Bybee | |
| B Sengül | |||
| D R Booth | |||
| H J Lachmann | |||
| J R Gallimore | |||
| M Soytürk | |||
| M Tunca | |||
| P N Hawkins | |||
| S Akar | |||
| S E Booth | |||
| T U Yavuzşen | |||
| P2860 | cites work | Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis | Q28212112 |
| Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness | Q33658740 | ||
| A candidate gene for familial Mediterranean fever | Q34065122 | ||
| Familial Mediterranean fever: prevalence, penetrance and genetic drift | Q34088721 | ||
| C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease | Q34311841 | ||
| The spectrum of Familial Mediterranean Fever (FMF) mutations | Q34314032 | ||
| Acute phase response in familial Mediterranean fever | Q35550951 | ||
| Familial Mediterranean fever. A survey of 470 cases and review of the literature | Q40051008 | ||
| The characterization of soluble amyloid prepared in water | Q40349915 | ||
| Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study | Q40517425 | ||
| Familial Mediterranean fever (FMF) mutations occur frequently in the Greek-Cypriot population of Cyprus | Q40576728 | ||
| Clinical versus genetic diagnosis of familial Mediterranean fever | Q40622322 | ||
| Criteria for the diagnosis of familial Mediterranean fever | Q40645936 | ||
| Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis | Q40647672 | ||
| Long-term colchicine treatment in children with familial mediterranean fever | Q40746167 | ||
| Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever | Q40808965 | ||
| Familial Mediterranean fever in Turkey. A report of twenty cases | Q40927013 | ||
| Amyloidosis as the sole manifestation of familial Mediterranean fever (FMF). Further evidence of its genetic nature | Q40987119 | ||
| Amyloidosis in familial Mediterranean fever. An independent genetically determined character | Q40994836 | ||
| The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study | Q47733783 | ||
| Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever | Q56288694 | ||
| Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia | Q61560910 | ||
| Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis | Q72530541 | ||
| Familial Mediterranean fever | Q74309346 | ||
| Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene | Q74510628 | ||
| Acute phase response and evolution of familial Mediterranean fever | Q77397098 | ||
| Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum | Q77634439 | ||
| The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever | Q78600172 | ||
| CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group | Q81178841 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| patient | Q181600 | ||
| familial Mediterranean fever | Q1144618 | ||
| MEFV innate immuity regulator, pyrin | Q11681842 | ||
| negative regulation of inflammatory response | Q14861060 | ||
| heterozygosity | Q124059385 | ||
| P304 | page(s) | 746-50 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations | |
| P478 | volume | 45 |
| Q90136131 | A 5-year-old girl with recurrent fever |
| Q21261477 | A novel insertion mutation identified in exon 10 of the MEFV gene associated with Familial Mediterranean Fever |
| Q55389099 | A rare cause of fever in an adult: a case of familial Mediterranean fever. |
| Q40108109 | A variant allele of the Mediterranean-fever gene increases the severity of gout |
| Q40311003 | Acute phase response and oxidative stress status in familial Mediterranean fever (FMF). |
| Q40243529 | As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio |
| Q40314835 | Assessment of cardiac functions using tissue Doppler imaging in children with familial Mediterranean fever |
| Q40043448 | Assessment of myocardial repolarisation parameters in patients with familial Mediterranean fever |
| Q40151444 | Association of familial Mediterranean fever in Turkish children with inflammatory bowel disease |
| Q36714318 | Autoinflammatory diseases |
| Q37834021 | Autoinflammatory diseases and cardiovascular manifestations. |
| Q40326095 | Autoinflammatory syndromes/fever syndromes |
| Q40238732 | Can serum fetuin-A be regarded as an inflammatory marker among patients with familial Mediterranean fever? |
| Q38865019 | Canakinumab for the treatment of familial Mediterranean fever. |
| Q49991652 | Canakinumab treatment in renal transplant recipients with familial Mediterranean fever. |
| Q44124984 | Cardiac manifestations of Familial Mediterranean fever |
| Q33854871 | Changes in Cerebral Blood Flow in Patients with Familial Mediterranean Fever |
| Q37808103 | Chronic inflammation in FMF: markers, risk factors, outcomes and therapy |
| Q37898725 | Clinical immunology review series: An approach to the patient with a periodic fever syndrome. |
| Q93162500 | Coexistence of Mixed Connective Tissue Disease and Familial Mediterranean Fever in a Japanese Patient |
| Q37872631 | Coexistence of vasculitides with familial Mediterranean fever |
| Q36774843 | Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever--a randomized controlled noninferiority trial |
| Q35670473 | Concurrent systemic AA amyloidosis can discriminate primary sclerosing cholangitis from IgG4-associated cholangitis |
| Q40100206 | Correlation of Secretory Activity of Neutrophils With Genotype in Patients With Familial Mediterranean Fever |
| Q37207033 | Developments in the scientific and clinical understanding of autoinflammatory disorders |
| Q40087177 | Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants |
| Q40054045 | Does familial Mediterranean fever affect cognitive function in children? Electrophysiological preliminary study |
| Q48089402 | Does thiol-disulphide balance show oxidative stress in different MEFV mutations? |
| Q40313887 | Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period. |
| Q26775286 | EULAR recommendations for the management of familial Mediterranean fever |
| Q40459503 | Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. |
| Q40242170 | Effect of chronic periodontitis on serum and gingival crevicular fluid oxidant and antioxidant status in patients with familial Mediterranean fever before and after periodontal treatment |
| Q40068527 | Egyptian tale from India: application of whole-exome sequencing in diagnosis of atypical familial Mediterranean fever. |
| Q47255463 | Evaluation of Subclinical Atherosclerosis by Ultrasound Radiofrequency Data Technology in Patients With Familial Mediterranean Fever |
| Q37296436 | Evaluation of arterial stiffness with plasma GGT levels and pulse wave velocity measurement in patients with FMF. |
| Q39028024 | Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation |
| Q40418469 | Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis |
| Q36112547 | Evaluation of the Mean Platelet Volume and Red Cell Distribution Width in FMF: Are They Related to Subclinical Inflammation or Not? |
| Q58593824 | Familial Mediterranean Gene (MEFV) Mutation in Parents of Children with Familial Mediterranean Fever: What Are the Exceptions? |
| Q37892998 | Familial Mediterranean fever and seronegative arthritis. |
| Q40182095 | Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation |
| Q40254151 | Familial Mediterranean fever in heterozygotes: are we able to accurately diagnose the disease in very young children? |
| Q37366257 | Familial Mediterranean fever with a single MEFV mutation: where is the second hit? |
| Q39380468 | Familial Mediterranean fever, review of the literature. |
| Q40074680 | Familial Mediterranean fever-associated diseases in children. |
| Q37296449 | Familial Mediterranean fever: An updated review |
| Q26751292 | Familial Mediterranean fever: current perspectives |
| Q39845776 | Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation. |
| Q33674457 | Familial mediterranean Fever: a retrospective clinical and molecular study in the East of anatolia region of Turkey |
| Q40054594 | Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis. |
| Q40221068 | Functional gastrointestinal disorders in patients with familial Mediterranean fever. |
| Q35086225 | Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice |
| Q28243289 | Hereditary auto-inflammatory disorders and biologics |
| Q40173210 | Heterozygote forms of familial Mediterranean fever can be manifested in adults as myofacial pain syndrome |
| Q36903094 | High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection |
| Q24631660 | Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*) |
| Q41964461 | Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? |
| Q36306285 | Killer Cell Immunoglobulin-Like Receptor (KIR) Genotype Distribution in Familial Mediterranean Fever (FMF) Patients |
| Q40411468 | Left ventricular diastolic function evaluated with tissue Doppler imaging in children with familial Mediterranean fever. |
| Q44736370 | Leucopenia and familial Mediterranean Fever |
| Q50170781 | Long-term follow-up of paediatric MEFV carriers |
| Q53590154 | Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice. |
| Q43974912 | MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients |
| Q40251072 | MEFV gene mutations in Turkish children with juvenile idiopathic arthritis. |
| Q40227432 | MEFV gene variations in patients with systemic lupus erythematosus |
| Q40256420 | MEFV gene variations in patients with systemic lupus erythematosus |
| Q39189860 | MEFV mutations in Egyptian children with systemic-onset juvenile idiopathic arthritis. |
| Q48097581 | MTHFR gene C677T and A1298C variants are associated with FMF risk in a Turkish cohort. |
| Q40135318 | Mean Platelet Volume and Splenomegaly as Useful Markers of Subclinical Activity in Egyptian Children with Familial Mediterranean Fever: A Cross-Sectional Study |
| Q40241017 | Mediterranean Fever gene analysis in the azeri turk population with familial mediterranean Fever: evidence for new mutations associated with disease |
| Q33798590 | Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals |
| Q90744138 | Monogenic autoinflammatory diseases in adults - a challenge to rheumatologic practice at the onset of the Polish national programme of interleukin 1 inhibitor treatment |
| Q40167665 | Neutrophil-lymphocyte ratio in children with familial Mediterranean fever: Original article |
| Q47949775 | New insights into the epigenetics of inflammatory rheumatic diseases. |
| Q34102054 | P wave dispersion and QT dispersion in adult Turkish migrants with familial mediterranean fever living in Germany |
| Q37218553 | Pathogenetic mechanisms of amyloid A amyloidosis. |
| Q40110559 | Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas. |
| Q40395893 | Periodic fever syndrome/autoinflammatory syndrome |
| Q64056617 | Periodic fever syndromes: beyond the single gene paradigm |
| Q34439639 | Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis. |
| Q37721227 | Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra--case report and review |
| Q40337408 | Prevalence of MEFV gene mutations and their clinical correlations in Turkish children with Henoch-Schönlein purpura |
| Q33684995 | Profile of blood cells and inflammatory mediators in periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome. |
| Q40164028 | Protracted arthritis in a Japanese patient with familial Mediterranean fever |
| Q90558373 | Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients |
| Q28596027 | Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS |
| Q40304701 | QT dispersion is not increased in familial Mediterranean fever |
| Q40260688 | Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease |
| Q90290826 | Recurrence of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome after tonsillectomy: case-based review |
| Q40164673 | Relation of fragmented QRS to tissue Doppler-derived parametersin patients with familial Mediterranean fever |
| Q40138008 | Relationship between periodontal destruction and gene mutations in patients with familial Mediterranean fever. |
| Q37848210 | Renal amyloidosis in children |
| Q28066401 | Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome |
| Q40170055 | Risk factors for subclinical inflammation in children with Familial Mediterranean fever |
| Q40070578 | Role of genetics in familial Mediterranean fever |
| Q37533429 | Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever |
| Q47644779 | Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever. |
| Q58703969 | Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report |
| Q35659928 | Systemic arthritis in children: a review of clinical presentation and treatment |
| Q37215910 | Systemic lupus erythematosus and familial Mediterranean fever: a possible negative association between the two disease entities--report of four cases and review of the literature |
| Q40351164 | TLR polymorphisms in FMF: association of TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly, Thre399Ile) polymorphisms and myeloid cell TLR-2 and TLR-4 expression with the development of secondary amyloidosis in FMF. |
| Q37629698 | The "other" vasculitis syndromes and kidney involvement |
| Q40348928 | The Familial Mediterranean Fever Gene as a Modifier of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome |
| Q92921941 | The Pyrin Inflammasome in Health and Disease |
| Q40082907 | The Relationship Among the Level of Serum Amyloid A, High-Density Lipoprotein and Microalbuminuria in Patients With Familial Mediterranean Fever. |
| Q40096019 | The Relationship Between Atherogenic Index and Carotid Artery Atherosclerosis in Familial Mediterranean Fever |
| Q37494036 | The clinical spectrum of 94 patients carrying a single mutated MEFV allele |
| Q40138639 | The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever |
| Q40404001 | The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease. |
| Q40437279 | The evaluation of carotid intima-media thickness in children with familial Mediterranean fever |
| Q36521208 | The expanded clinical profile and the efficacy of colchicine therapy in Egyptian children suffering from familial Mediterranean fever: a descriptive study |
| Q39443996 | The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation |
| Q38400573 | The myths we believed in familial Mediterranean fever: what have we learned in the past years? |
| Q37138764 | The presence of MEFV gene mutations in patients with primary osteoarthritis who require surgery. |
| Q40415336 | The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study |
| Q40426204 | The relationship between the MEFV genotype, clinical features, and cytokine-inflammatory activities in patients with familial mediterranean fever |
| Q36981046 | The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach |
| Q33742607 | Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever |
| Q33767097 | Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens |
| Q38075002 | Unexplained recurrent fever: when is autoinflammation the explanation? |
| Q37857761 | Vascular comorbidities in familial Mediterranean fever |
| Q47868922 | Very Rare Presentation of Cerebrovascular Accident in 20-Year-Old Man With Familial Mediterranean Fever-Case Report. |
| Q38681895 | What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review |
Search more.